Dr. Smith is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
55 Fruit St
Boston, MA 02114Phone+1 617-724-5257Fax+1 617-726-4899- Is this information wrong?
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1994 - 1997- Brigham and Women's HospitalResidency, Internal Medicine, 1992 - 1994
Duke University School of MedicineClass of 1992
Certifications & Licensure
MA State Medical License 1994 - 2025- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Zoledronic Acid to Prevent Bone Loss During Androgen Deprivation Therapy for Prostate Cancer Start of enrollment: 2003 Sep 01
- Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy Start of enrollment: 2006 Mar 01
- Prospective Study of Insulin Resistance and Cardiovascular Disease Risk During Androgen Deprivation Therapy for Prostate Cancer Start of enrollment: 2002 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- Radiographic Progression-Free Survival and Clinical Progression-Free Survival as Potential Surrogates for Overall Survival in Men With Metastatic Hormone-Sensitive Pro...Susan Halabi, Akash Roy, Larysa Rydzewska, Siyuan Guo, Peter Godolphin, Maha Hussain, Catherine Tangen, Ian Thompson, Wanling Xie, Michael A Carducci, Matthew R Smith,...> ;Journal of Clinical Oncology. 2024 Mar 20
- Cardiac Structural Changes and Declining Cardiorespiratory Fitness During Androgen Deprivation Therapy for Prostate Cancer.Richard J Lee, Erika Meneely, Kara Olivier, Aaron L Baggish, Timothy W Churchill, Matthew R Smith, M Dror Michaelson, James Sawalla Guseh, Meagan M Wasfy, Philip J Saylor> ;Journal of the American Society of Echocardiography. 2024 Mar 16
- Phase I Study of ORIC-101, a Glucocorticoid Receptor Antagonist, in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer Prog...Wassim Abida, Andrew W Hahn, Neal Shore, Neeraj Agarwal, Paul Sieber, Matthew R Smith, Tanya Dorff, Paul Monk, Matthew Rettig, Rupal Patel, Anne Page, Maureen Duff, Ro...> ;Clinical Cancer Research. 2024 Mar 15
- Join now to see all
Other
- Initial hormone therapy for metastatic prostate cancerSmith MR, Lee RJ
http://www.uptodate.com/contents/initial-hormone-therapy-for-metastatic-prostate-cancer
UpToDate, Wolters Kluwer Health - 2013-04-09 - Side effects of androgen deprivation therapySmith MR, Crawford ED
http://www.uptodate.com/contents/side-effects-of-androgen-deprivation-therapy
UpToDate, Wolters Kluwer Health - 2013-03-27
Press Mentions
Darolutamide Ups Survival in Metastatic Hormone-Sensitive Prostate CancerFebruary 17th, 2022- Another PARP Inhibitor Active in BRCA-Mutant Prostate CancerFebruary 8th, 2022
- Accelerating Precision Medicine in Metastatic Prostate CancerNovember 17th, 2020
- Join now to see all
Hospital Affiliations
Massachusetts General HospitalBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
